91059-6 |
Kingella kingae DNA |
PrThr |
Bld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Kingella kingae DNA [Presence] in Blood by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91059-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
K kingae DNA Bld Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K kingae; K kingella; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Moraxella kingae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9106-6 |
Fluid intake.total |
VRat |
^Patient |
10H |
Qn |
|
|
ACTIVE |
Fluid intake total 10 hour |
|
MIN |
DefinitionDescription |
|
|
ml/10 H |
|
|
|
|
|
|
IO_IN.TIMED.MOLEC |
|
9106-6 |
|
|
|
|
|
|
|
|
0 |
Fluid intake total 10h |
|
|
|
|
|
10 hours; 10HR; Fld; Flow; Fluid intake total; IO_INTAKE; IO_INTAKE.TIMED.MOLEC; QNT; Quan; Quant; Quantitative; Tot; Totl; Volume rate; vRate |
2.48 |
1.0i |
|
|
|
|
|
|
|
mL/(10.h) |
|
|
|
0 |
91060-4 |
Helicobacter pylori DNA |
PrThr |
Tiss |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Helicobacter pylori DNA [Presence] in Tissue by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91060-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
H pylori DNA Tiss Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C pylori; Campylobacter pylori; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gastro; Gastroenterology; GI; H pyl; H pylori; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91061-2 |
Helicobacter pylori DNA |
PrThr |
Stool |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Helicobacter pylori DNA [Presence] in Stool by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91061-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
H pylori DNA Stl Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C pylori; Campylobacter pylori; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; H pyl; H pylori; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91062-0 |
Bacteria |
Prid |
Platelets^BPU |
Pt |
Nom |
Anaerobic culture |
|
ACTIVE |
Bacteria identified in Platelets from Blood product unit by Anaerobe culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91062-0 |
|
Anaerobic culture |
|
|
Both |
|
|
|
0 |
Bacteria Plts BPU Anaerobe Cult |
|
|
|
|
|
Anaero; Anaerobe; Anaerobe Cult; Bact; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Platelet; Plt; Plts; Point in time; Random; Thrb; Thrombocyte; Thrombocytes |
2.78 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
91063-8 |
Bacteria |
Prid |
Platelets^BPU |
Pt |
Nom |
Aerobic culture |
|
ACTIVE |
Bacteria identified in Platelets from Blood product unit by Aerobe culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91063-8 |
|
Aerobic culture |
|
|
Both |
|
|
|
0 |
Bacteria Plts BPU Aerobe Cult |
|
|
|
|
|
Aerobe; Aerobe Cult; Aerobed; Bact; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Platelet; Plt; Plts; Point in time; Random; Thrb; Thrombocyte; Thrombocytes |
2.78 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
91064-6 |
Dengue virus NS1 Ag |
PrThr |
Ser/Plas |
Pt |
Ord |
IA |
|
ACTIVE |
Dengue virus NS1 Ag [Presence] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91064-6 |
|
IA |
|
|
Both |
|
|
|
0 |
DENV NS1 Ag SerPl Ql IA |
|
|
|
|
|
Antigen; Antigens; Breakbone fever; Dengue fever; Denv; DENV NS1; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NS1; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91065-3 |
14-3-3 protein |
PrThr |
Tiss |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
14-3-3 protein [Presence] in Tissue by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
91065-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
14-3-3 protein Tiss Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CJ; CJD; Creutzfeldt-Jacob Disease; Creutzfeldt-Jakob Disease; DNA NUCLEIC ACID PROBE; DNA probe; III; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prot; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serology; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91066-1 |
Enterovirus RNA |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Enterovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91066-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
EV RNA Lower resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
91067-9 |
Enterovirus RNA |
PrThr |
Cornea/Conjunctiva |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Enterovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91067-9 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
EV RNA Corn/Cnjt Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91068-7 |
Enterovirus RNA |
PrThr |
Stool |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Enterovirus RNA [Presence] in Stool by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91068-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
EV RNA Stl Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91069-5 |
Enterovirus RNA |
PrThr |
Urine |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Enterovirus RNA [Presence] in Urine by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91069-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
EV RNA Ur Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9107-4 |
Fluid intake.total |
VRat |
^Patient |
12H |
Qn |
|
|
ACTIVE |
Fluid intake total 12 hour |
|
MIN |
DefinitionDescription |
|
|
ml/12 H |
|
|
|
|
|
|
IO_IN.TIMED.MOLEC |
|
9107-4 |
|
|
|
|
|
|
|
|
0 |
Fluid intake total 12h |
|
|
|
|
|
12 hours; 12HR; Fld; Flow; Fluid intake total; IO_INTAKE; IO_INTAKE.TIMED.MOLEC; QNT; Quan; Quant; Quantitative; Tot; Totl; Volume rate; vRate |
2.48 |
1.0i |
|
|
|
|
|
|
|
mL/(12.h) |
|
|
|
0 |
91070-3 |
Hepatitis A virus RNA |
PrThr |
Stool |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Hepatitis A virus RNA [Presence] in Stool by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91070-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HAV RNA Stl Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; HAV; Hep; Hep A; Hepatis; Hepatit; Hepatitis; Hepatitis type A; Hepatology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91071-1 |
Hepatitis E virus RNA |
PrThr |
Stool |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Hepatitis E virus RNA [Presence] in Stool by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91071-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HEV RNA Stl Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; HEV RNA; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.72 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.72: DefinitionDescription: updated URL; |
0 |
91072-9 |
Influenza virus A subtype |
Prid |
Respiratory system specimen.lower |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Influenza virus A subtype [Identifier] in Lower respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91072-9 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
FLUAV Subtyp Lower resp NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV Subtyp; FLUV; Fowl plague; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Respiratory; RS; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
91073-7 |
Human papilloma virus genotype |
Prid |
Tiss |
Pt |
Nom |
Probe.amp.tar |
|
ACTIVE |
Human papilloma virus genotype [Identifier] in Tissue by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91073-7 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
HPV Gentyp Tiss NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; Gentyp; HPV; Human papillomavirus; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification |
2.72 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91074-5 |
Phlebovirus sp RNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Phlebovirus sp RNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91074-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Phlebovirus sp RNA CSF Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91075-2 |
Rabies virus Ag |
PrThr |
Saliva |
Pt |
Ord |
IA |
|
ACTIVE |
Rabies virus Ag [Presence] in Saliva (oral fluid) by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91075-2 |
|
IA |
|
|
Both |
|
|
|
0 |
RABV Ag Sal Ql IA |
|
|
|
|
|
Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lyssavirus; MEIA; Microbiology; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Sal; Screen; SUDS |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91076-0 |
Rabies virus Ag |
PrThr |
Tiss |
Pt |
Ord |
IA |
|
ACTIVE |
Rabies virus Ag [Presence] in Tissue by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91076-0 |
|
IA |
|
|
Both |
|
|
|
0 |
RABV Ag Tiss Ql IA |
|
|
|
|
|
Antigen; Antigens; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; Lyssavirus; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; SUDS; Tissue; Tissue, unspecified |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91077-8 |
Measles virus RNA |
PrThr |
Respiratory system specimen.upper |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Measles virus RNA [Presence] in Upper respiratory specimen by NAA with probe detection |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91077-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
MeV RNA Upper resp Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Lungs; MeV; Microbiology; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RS; Rubeola; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp |
2.77 |
2.65 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
91078-6 |
Zika virus RNA |
PrThr |
Bld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Zika virus RNA [Presence] in Blood by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91078-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
ZIKV RNA Bld Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; ZIKV; ZIKV RNA |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
91079-4 |
Zika virus RNA |
PrThr |
Placenta |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Zika virus RNA [Presence] in Placenta by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91079-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
ZIKV RNA Placenta Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Placent; Placental; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; ZIKV; ZIKV RNA |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9108-2 |
Fluid intake.total |
VRat |
^Patient |
24H |
Qn |
|
|
ACTIVE |
Fluid intake total 24 hour |
|
MIN |
DefinitionDescription |
|
|
mL/24 H |
|
|
|
|
|
|
IO_IN.TIMED.MOLEC |
|
9108-2 |
|
|
|
|
|
|
|
|
0 |
Fluid intake total 24h |
|
|
|
|
|
1 day; 24 hours; 24HR; Fld; Flow; Fluid intake total; IO_INTAKE; IO_INTAKE.TIMED.MOLEC; QNT; Quan; Quant; Quantitative; Tot; Totl; Volume rate; vRate |
2.48 |
1.0i |
|
|
|
|
|
|
|
mL/(24.h) |
|
|
|
0 |
91080-2 |
Zika virus Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
IA |
|
ACTIVE |
Zika virus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
91080-2 |
|
IA |
|
|
Both |
|
|
|
0 |
ZIKV IgG SerPl Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; ZIKV |
2.65 |
2.65 |
|
|
|
|
|
|
|
|
|
|
|
0 |